Charalampos I. Liakos

Dr. Charalampos I. Liakos


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2020 in American Journal of Cardiovascular Drugs
Verified
Journal Article
Closed access
PDF file
CLCharalampos I. Liakos
Charalampos I. Liakos
DPDimitrios P. Papadopoulos
Dimitrios P. Papadopoulos
ESElias A. Sanidas
Elias A. Sanidas
MMMaria I. Markou
Maria I. Markou
EHErifili E. Hatziagelaki
Erifili E. Hatziagelaki
JBJohn D. Barbetseas
John D. Barbetseas

14 August 2015 in American Journal of Hypertension
Verified
Journal Article
Open access
PDF file
CLCharalampos I. Liakos
Charalampos I. Liakos
ESElias A. Sanidas
Elias A. Sanidas
DPDespoina N. Perrea
Despoina N. Perrea
CGCharalampos A. Grassos
Charalampos A. Grassos
VCVasiliki Chantziara
Vasiliki Chantziara
DPDimitrios P. Papadopoulos
Dimitrios P. Papadopoulos
High normal blood pressure (BP; 130–139/85–89mm Hg) is related with increased cardiovascular (CV) risk compared to normal BP (120–129/80–84mm Hg) or/and optimal BP (<120/80mm Hg). Low apelin plasma levels have been associated with arterial hypertension and atherosclerosis, while high visfatin plasma levels may promote vascular inflammation and atherosclerotic plaque destabilization and have been evaluated as a marker for identifying stages of essential hypertension. We sought to compare the apelin and visfatin plasma levels between subjects with high normal BP and subjects with normal or optimal BP matched for age, gender, smoking, and body mass index (BMI). Twenty-five subjects with high normal BP (office BP 136±3/88±2mm Hg, age 57±4 years, 76% males, 32% smokers, BMI 24.0±1.7kg/m 2 ) and 35 subjects with normal or optimal BP (office BP 118±2/78±2mm Hg, age 55±7 years, 63% males, 29% smokers, BMI 23.2±1.4kg/m 2 ) were studied. The apelin and visfatin plasma levels were determined with the enzyme-linked immunosorbent assay. Compared to normal or optimal BP subjects, apelin levels were significantly lower (205±108 vs. 325±152 pg/ml, P < 0.001) and visfatin levels significantly higher (11.0±2.0 vs. 7.2±0.9ng/ml, P = 0.002) in high normal BP subjects. No significant differences were found between the 2 groups ( P = NS) regarding the basic clinical characteristics, the glycemic/lipid profile, and the renal function parameters. The emerging, from the present study, data raise the hypothesis that lower apelin and higher visfatin plasma levels in high normal BP subjects compared to normal or optimal BP individuals could partially explain the higher CV risk of the high normal BP group.

13 May 2016 in Clinical Cardiology
Verified
Journal Article
Closed access
PDF file
NKNikolaos Kafkas
Nikolaos Kafkas
CLCharalampos I. Liakos
Charalampos I. Liakos
FZFilitsa Zoubouloglou
Filitsa Zoubouloglou
ODOurania Dagadaki
Ourania Dagadaki
SDStylianos Dragasis
Stylianos Dragasis
Konstantinos MakrisKonstantinos Makris
Konstantinos Makris

25 September 2014 in High Blood Pressure & Cardiovascular Prevention
Verified
Journal Article
Closed access
PDF file
CLCharalampos I. Liakos
Charalampos I. Liakos
CGCharalampos A. Grassos
Charalampos A. Grassos
DBDimitrios K. Babalis
Dimitrios K. Babalis

2 May 2017 in American Journal of Cardiovascular Drugs
Verified
Journal Article
Closed access
PDF file
CLCharalampos I. Liakos
Charalampos I. Liakos
DPDimitrios P. Papadopoulos
Dimitrios P. Papadopoulos
VKVasilios T. Kotsis
Vasilios T. Kotsis

1 January 2010 in Cardiology Research and Practice
Verified
Journal Article
Open access
PDF file
AMAndreas P. Michaelides
Andreas P. Michaelides
CLCharalampos I. Liakos
Charalampos I. Liakos
CACharalambos Antoniades
Charalambos Antoniades
Dimitrios TsiachrisDimitrios Tsiachris
Dimitrios Tsiachris
DSDimitrios Soulis
Dimitrios Soulis
CSChristodoulos I. Stefanadis
Christodoulos I. Stefanadis
Objectives. Mitral valve prolapse (MVP) is a known cause for false positive exercise test (ET). The purpose of this study was to establish additional electrocardiographic criteria to distinguish the false positive exercise results in patients with MVP.Methods. We studied 218 consecutive patients ( years, 103 males) with MVP (according to echocardiographic study), and positive treadmill ET was performed due to multiple cardiovascular risk factors or angina-like symptoms. A coronary angiography was performed to detect coronary artery disease (CAD).Results. From 218 patients, 90 (group A) presented with normal coronary arteries according to the angiography (false positive ET) while the rest 128 (group B) presented with CAD. ST-segment depression in hyperventilation phase was present in 54 patients of group A (60%) while only in 14 patients of group B (11%), .Conclusions. Presence of ST-segment depression in hyperventilation phase favors a false positive ET in patients with MVP.